VHL-SF2
VHL-SF2 is a VHL ligand, and can be used for synthesis of PROTACs[1]
Product Specifications
CAS Number
[3050690-24-6]
UNSPSC
12352005
Target
Ligands for E3 Ligase
Type
Reference compound
Related Pathways
PROTAC
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/vhl-sf2.html
Solubility
10 mM in DMSO
Smiles
CC(C)[C@H](C1=CC(C)=NO1)C(N2[C@@H](C[C@H](C2)S(F)(=O)=O)C(N[C@H](C3=CC=C(C4=C(N=CS4)C)C=C3)CC(OC(C)(C)C)=O)=O)=O
Molecular Formula
C31H39FN4O7S2
Molecular Weight
662.79
References & Citations
[1]Shah RR, et al. Structure-Guided Design and Optimization of Covalent VHL-Targeted Sulfonyl Fluoride PROTACs. J Med Chem. 2024 Mar 28;67 (6) :4641-4654.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Von Hippel-Lindau (VHL)
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
PT_40640-01 10 µg
Growth Arrest and DNA-Damage-Inducible Beta Human Recombinant (GADD45B Human)
Ask
View Details PT_40640-02 50 µg
Growth Arrest and DNA-Damage-Inducible Beta Human Recombinant (GADD45B Human)
Ask
View Details PT_40640-03 1 mg
Growth Arrest and DNA-Damage-Inducible Beta Human Recombinant (GADD45B Human)
Ask
View Details